In El Paso, individuals managing Type 2 diabetes may find relief in once-a-week insulin. This relatively new technology aims to make managing the condition less bothersome. A new insulin, Awiqli, was FDA-approved in March 2026 for weekly injection, marking a significant development in diabetes research.

Another insulin, insulin efsitora alfa, may also become available. For those prescribed once-a-week insulin, further guidance is available on how to effectively use this medication, including tips on injection, storage, and working with healthcare providers. Details on using once-a-week insulin can be found through platforms like GoodRx, which provides information on medication savings.